Publish in this journal
Journal Information
Vol. 68. Issue 1.
Pages 65 (January 2015)
Share
Share
Download PDF
More article options
Vol. 68. Issue 1.
Pages 65 (January 2015)
Image in cardiology
DOI: 10.1016/j.rec.2014.02.010
Full text access
Percutaneous Closure of a Giant Multiperforated Atrial Septal Aneurysm
Cierre percutáneo de aneurisma gigante multiperforado
Visits
...
Carlos Ortiz
Corresponding author
ortiz.bautista.carlos@gmail.com

Corresponding author:
, Roman Arnold, Benigno Ramos
Instituto de Ciencias del Corazón (ICICOR), Hospital Clínico Universitario de Valladolid, Valladolid, Spain
This item has received
...
Visits
(Daily data update)
Article information
Full Text
Download PDF
Statistics
Figures (1)
Full Text

A 69-year-old woman with a history of arterial hypertension, paroxysmal atrial fibrillation, giant multiperforated atrial septal aneurysm, and ischemic stroke 1 year previously, was admitted to our hospital with a new ischemic stroke episode, although she was on anticoagulant therapy with correct therapeutic index.

During hospital admission, the giant multiperforated atrial septal aneurysm was seen on transesophageal echocardiography (Figure A, asterisk) with a left-to-right shunt (Figure B, white arrows) at 4 levels. Although the effectiveness of percutaneous closure for preventing recurrent embolic events in this setting is not well established, we decided to perform a percutaneous closure with the atrial septal defect occluder Figulla® Flex II (Occlutech International AB, Sweden). The procedure was guided by transesophageal echocardiography (Figures C-F). Right femoral vein access was conducted in order to reach the right atrium. Afterwards, transeptal puncture with a 12F multipurpose catheter was performed and a 24-mm device was implanted. Nevertheless, we noticed that the left-to-right shunt persisted (Figure C, red arrow). To achieve total occlusion, a second 24-mm device was implanted through the septal defect without a final left-to-right shunt assessed by color Doppler (Figure D). Final apposition was confirmed by fluoroscopy (Figure E, red arrows) and 3D imaging from transesophageal echocardiography (Figure F). To avoid device-related thromboembolic events and due to the high risk of bleeding (HAS-BLED 3 points), our patient was discharged on anticoagulant therapy with dicoumarinic agents indefinitely and dual antiplatelet therapy with aspirin and clopidogrel for 1 month followed by aspirin for 5 months.

(0.27MB).
Copyright © 2014. Sociedad Española de Cardiología
Idiomas
Revista Española de Cardiología (English Edition)

Subscribe to our newsletter

Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.